You are here

gout

Few signs of gout pipeline flaring up

Few signs of gout pipeline flaring up

EP Vantage

Selecta Biosciences

Arthrosi Therapeutics

Atom Bioscience

Dyve Biosciences

Hinova Pharmaceuticals

Horizon Therapeutics

Jiangsu Hengrui Pharmaceuticals

Olatec Therapeutics

Shanton Bioscience

Flag link:

Gout Disease Control Suffered After FDA-Driven Price Hike: Study

Gout Disease Control Suffered After FDA-Driven Price Hike: Study

BioSpace

Flag link:

Takeda hit with another pay-for-delay lawsuit, this time on gout drug Colcrys

Takeda hit with another pay-for-delay lawsuit, this time on gout drug Colcrys

Fierce Pharma

Flag link:

Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon

Selecta, Sobi rout gout in pair of phase 3 trials that could challenge Horizon

Fierce Biotech

Selecta Biosciences

Horizon Therapeutics

Flag link:

Atom Bioscience reports positive Phase IIa chronic gout therapy trial data

Atom Bioscience reports positive Phase IIa chronic gout therapy trial data

Clinical Trials Arena

Atom Bioscience

clinical trials

Flag link:

Krystexxa Chronic Gout Medication Gets Expanded FDA Approval

Krystexxa Chronic Gout Medication Gets Expanded FDA Approval

Xtalks

Horizon Therapeutics

Flag link:

Orphan drug specialist Horizon looks to double down on its gout expertise with acquired rights to Arrowhead's RNAi med

Orphan drug specialist Horizon looks to double down on its gout expertise with acquired rights to Arrowhead's RNAi med

Endpoints

Horizon Therapeutics

Arrowhead Pharmaceuticals

Flag link:

A gout drug shows promise for Covid-19, but skeptics worry about trusting science by press release

A gout drug shows promise for Covid-19, but skeptics worry about trusting science by press release

Stat

Flag link:

InventisBio reels in $147M to push gout and breast cancer drugs along

InventisBio reels in $147M to push gout and breast cancer drugs along

Endpoints

Flag link:

Horizon Therapeutics initiates MIRROR trial evaluating KRYSTEXXA in combination with methotrexate

Horizon Therapeutics initiates MIRROR trial evaluating KRYSTEXXA in combination with methotrexate

Pharmaceutical Business Review

Horizon Therapeutics

clinical trials

uncontrolled gout

Flag link:

FDA Warns of Increased Risk of Death With Gout Medicine Uloric

FDA Warns of Increased Risk of Death With Gout Medicine Uloric

RAPS.org

Flag link:

Selecta lays off staff as R&D cash crunch looms

Selecta lays off staff as R&D cash crunch looms

Fierce Biotech

Selecta Biosciences

Flag link:

Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster

Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster

Endpoints

Flag link:

Public Citizen Calls on FDA to Withdraw Takeda Gout Drug

Public Citizen Calls on FDA to Withdraw Takeda Gout Drug

RAPS.org

Flag link:

Krystexxa shows signs of life as Horizon keeps pushing sales force expansion

Krystexxa shows signs of life as Horizon keeps pushing sales force expansion

Fierce Pharma

Flag link:

Ironwood zeroes in on primary care doctors with new gout combo med Duzallo

Ironwood zeroes in on primary care doctors with new gout combo med Duzallo

Fierce Pharma

Ironwood Pharmaceuticals

Flag link:

Ironwood looks to boost gout franchise as FDA delivers OK for Duzallo

Ironwood looks to boost gout franchise as FDA delivers OK for Duzallo

Endpoints

Flag link:

AZ jilts gout med Zurampic with $230M rights sale to Grunenthal

AZ jilts gout med Zurampic with $230M rights sale to Grunenthal

Fierce Pharma

Flag link:

AstraZeneca hands off Zurampic marketing rights to Ironwood for $100 million

AstraZeneca hands off Zurampic marketing rights to Ironwood for $100 million

BioPharma Dive

Ironwood Pharmaceuticals

Flag link:

AstraZeneca bags EU approval for gout drug Zurampic as it eyes $500M in sales

AstraZeneca bags EU approval for gout drug Zurampic as it eyes $500M in sales

Fierce Pharma

Flag link:

Pages